Deregulation of miR-520d-3p promotes hepatocellular carcinoma development via lncRNA MIAT regulation and EPHA2 signaling activation
Authors:
Open Access
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 109, 1630-1639
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Transcriptome sequencing during mouse brain development identifies long non‐coding RNAs functionally involved in neurogenic commitmentThe EMBO Journal, 2013
- Eph receptors and ephrins as targets for cancer therapyJournal of Cellular and Molecular Medicine, 2012
- The EphA2 Receptor Drives Self-Renewal and Tumorigenicity in Stem-like Tumor-Propagating Cells from Human GlioblastomasCancer Cell, 2012
- The multifaceted roles of Eph/ephrin signaling in breast cancerCell Adhesion & Migration, 2012
- Overexpression of EphA2, MMP‐9, and MVD‐CD34 in hepatocellular carcinoma: Implications for tumor progression and prognosisHepatology Research, 2009
- MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neureceptor status in breast cancerBreast Cancer Research, 2009
- Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarctionJournal of Human Genetics, 2006
- MicroRNA maturation: stepwise processing and subcellular localizationThe EMBO Journal, 2002
- Matrix metalloproteinasesEuropean Journal of Cancer, 2000
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993